India to Singapore: Plasma Export Trade Route
India has recorded 16,941 verified shipments of Plasma exported to Singapore, representing a combined trade value of $231.6K USD. This corridor is served by 75 active Indian exporters, with an average shipment value of $14 USD. The leading Indian exporter is S S SERUMS, which accounts for 39% of total export value with 54 shipments worth $91.4K USD. On the buying side, MP BIOMEDICALS ASIA PACIFIC PTE LTD is the largest importer in Singapore with $54.4K USD in purchases. The top 3 suppliers — S S SERUMS, ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED, JOHNSON & JOHNSON PRIVATE LIMITED — together control 52% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Singapore Plasma corridor is one of India's established pharmaceutical export routes, with 16,941 shipments documented worth a combined $231.6K USD. The route is dominated by S S SERUMS, which alone accounts for roughly 39% of all export value, reflecting the consolidated nature of India's plasma manufacturing sector.
Across 75 active suppliers, the average shipment value stands at $14 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with plasma's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 16.9%, placing it at rank #5 among India's top plasma export destinations globally.
On the import side, key buyers of Indian plasma in Singapore include MP BIOMEDICALS ASIA PACIFIC PTE LTD, MP BIOMEDICALS ASIA PACIFIC PTE LIMITED, LABCORP DEVELOPMENT (ASIA) PTE.LTD. and 175 others. MP BIOMEDICALS ASIA PACIFIC PTE LTD is the single largest importer with 39 shipments valued at $54.4K USD.
Route Characteristics
- Average transit32 days
- Peak seasonQ1
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#5
- Annual growth+16.9%
- Demand growth+16.4%
- Regulatory ease83/100
Top 10 Indian Plasma Exporters to Singapore
Showing top 10 of 75 Indian suppliers exporting Plasma to Singapore, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | S S SERUMS Avg $1.7K per shipment | 54 | $91.4K | 39.4% |
| 2 | ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED Avg $12 per shipment | 1,346 | $16.7K | 7.2% |
| 3 | JOHNSON & JOHNSON PRIVATE LIMITED Avg $8 per shipment | 1,686 | $13.0K | 5.6% |
| 4 | ASTRAZENECA PHARMA INDIA LIMITED Avg $8 per shipment | 1,531 | $12.9K | 5.5% |
| 5 | NOVARTIS HEALTHCARE PRIVATE LIMITED Avg $8 per shipment | 1,437 | $11.2K | 4.8% |
| 6 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED Avg $9 per shipment | 1,124 | $10.4K | 4.5% |
| 7 | NOVO NORDISK INDIA PRIVATE LIMITED Avg $10 per shipment | 982 | $9.6K | 4.2% |
| 8 | PPD PHARMACEUTICAL DEVELOPMENT INDIA PRIVATE LIMIT Avg $9 per shipment | 876 | $8.2K | 3.5% |
| 9 | 3S CORPORATION Avg $1.1K per shipment | 5 | $5.7K | 2.5% |
| 10 | ICON CLINICAL RESEARCH INDIA PRIVATE LIMITED Avg $8 per shipment | 667 | $5.4K | 2.3% |
This table shows the top 10 of 75 Indian companies exporting plasma to Singapore, ranked by total trade value. The listed exporters are: S S SERUMS, ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED, JOHNSON & JOHNSON PRIVATE LIMITED, ASTRAZENECA PHARMA INDIA LIMITED, NOVARTIS HEALTHCARE PRIVATE LIMITED, GLAXOSMITHKLINE PHARMACEUTICALS LIMITED, NOVO NORDISK INDIA PRIVATE LIMITED, PPD PHARMACEUTICAL DEVELOPMENT INDIA PRIVATE LIMIT, 3S CORPORATION , ICON CLINICAL RESEARCH INDIA PRIVATE LIMITED. S S SERUMS is the dominant supplier with 54 shipments worth $91.4K USD, giving it a 39% market share. The top 3 suppliers together account for 52% of the total trade value on this route.
Showing top 10 of 75 total Indian exporters on the India to Singapore Plasma export route.
Top 10 Plasma Importers in Singapore
Showing top 10 of 178 known buyers in Singapore receiving Plasma shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian plasma in Singapore include MP BIOMEDICALS ASIA PACIFIC PTE LTD, MP BIOMEDICALS ASIA PACIFIC PTE LIMITED, LABCORP DEVELOPMENT (ASIA) PTE.LTD., LABCORP DEVELOPMENT ASIA PTE LIMITE, ICON CENTRAL LABORATORIES, among 178 total buyers. The largest importer is MP BIOMEDICALS ASIA PACIFIC PTE LTD, accounting for $54.4K USD across 39 shipments — representing 23% of all plasma imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MP BIOMEDICALS ASIA PACIFIC PTE LTD | 39 | $54.4K | 23.5% |
| 2 | MP BIOMEDICALS ASIA PACIFIC PTE LIMITED | 15 | $36.9K | 16.0% |
| 3 | LABCORP DEVELOPMENT (ASIA) PTE.LTD. | 3,700 | $35.6K | 15.4% |
| 4 | LABCORP DEVELOPMENT ASIA PTE LIMITE | 2,311 | $20.8K | 9.0% |
| 5 | ICON CENTRAL LABORATORIES | 1,980 | $15.9K | 6.9% |
| 6 | PPD LABORATORIES CENTRAL LAB SG. | 1,363 | $12.5K | 5.4% |
| 7 | PPD GLOBAL CENTRAL LABS | 735 | $11.3K | 4.9% |
| 8 | PPD CENTRAL LAB | 937 | $8.6K | 3.7% |
| 9 | FOR THE ORDER OF | 4 | $4.5K | 2.0% |
| 10 | TO THE ORDER OF INVOICE RAISED TO | 2 | $4.4K | 1.9% |
Showing top 10 of 178 Plasma importers in Singapore on this route.
Top 10 Plasma Formulations Imported by Singapore
Showing top 10 of 1,694 product formulations shipped on the India to Singapore Plasma route, ranked by trade value
Singapore imports a wide range of plasma formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — BIOLOGICAL SUBSTANCE CATEGORY B HUMAN PLASMA/SERUM - HBSAG POSITIVE PLASMA LOT NO. SBIP-101/23 TO SBIP-126/23 MANUFACTURING . DT — accounts for $11.4K USD across 1 shipments. There are 1,694 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BIOLOGICAL SUBSTANCE CATEGORY B HUMAN PLASMA/SERUM - HBSAG POSITIVE PLASMA LOT NO. SBIP-101/23 TO SBIP-126/23 MANUFACTURING . DT | 1 | $11.4K | 4.9% |
| 2 | HUMAN BLOOD (1ML/02VIAL),SERUM (1ML/01VIAL),PLASMA (1ML/02VIALS),URINE (1ML/03VIALS) SAMPLES-FOR TESTING PURPOSE ONLY | 1,338 | $10.6K | 4.6% |
| 3 | BIOLOGICAL SUBSTANCE CATEGORY B (HUMAN PLASMA/SERUM) - HBSAG POSITIVE PLASMA (LOT NO. SBIP-205/23 TO SBIP-223/23 MFG. DT | 1 | $9.2K | 4.0% |
| 4 | HUMAN BLOOD (03ML/03VIAL),SERUM (2ML/01VIAL),PLASMA (5ML/02VIALS),URINE (6ML/03VIALS), BLOOD TISSUE/SLIDE (2ML/01VIALS) | 888 | $8.8K | 3.8% |
| 5 | BIOLOGICAL SUBSTANCE CATEGORY B HUMAN PLASMA/SERUM - HBSAG POSITIVE PLASMA LOT NO. SBIP-135/23 TO SBIP-170/23 MANUFACTURING . DT | 1 | $7.0K | 3.0% |
| 6 | Plasma Substitute for Intravenous Infusi | 5 | $5.7K | 2.5% |
| 7 | HUMAN BLOOD/SERUM/PLASMA/URINETISSUE | 301 | $5.6K | 2.4% |
| 8 | HUMAN BLOOD SAMPLES (06 VIALS/04ML),PLASMA SAMPLES (04VIALS/05ML) FOR TESTING PURPOSE ONLY | 545 | $5.4K | 2.3% |
| 9 | HUMAN BLOOD/SERUM/PLASMA/URINE | 346 | $4.6K | 2.0% |
| 10 | HUMAN -BLOOD/SERUM/PLASMA/URINESAMPLES | 374 | $4.4K | 1.9% |
Showing top 10 of 1,694 Plasma formulations imported by Singapore on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 5000 shipments. Transit time averages 32 days by sea.
Market Dynamics
India's plasma exports to Singapore are driven primarily by a handful of large-scale manufacturers. S S SERUMS with 54 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 75 active exporters signals a competitive but concentrated market — buyers in Singapore benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — S S SERUMS, ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED, JOHNSON & JOHNSON PRIVATE LIMITED — together account for 52% of total trade value on this route. The average shipment value of $14 USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as human blood (1ml/02vial),serum (1ml/01vial),plasma (1ml/02vials),urine (1ml/03vials) samples-for testing purpose only and biological substance category b (human plasma/serum) - hbsag positive plasma (lot no. sbip-205/23 to sbip-223/23 mfg. dt, suggesting that buyers in Singapore tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MP BIOMEDICALS ASIA PACIFIC PTE LTD is the largest importer with 39 shipments worth $54.4K USD — representing 23% of all plasma imports from India on this route. A total of 178 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $231.6K
- Avg. Shipment
- $14
- Suppliers
- 75
- Buyers
- 178
- Transit (Sea)
- ~32 days
- Annual Growth
- +16.9%
Reverse Direction
Singapore → India — Plasma (Import)Other Plasma Routes
Unlock the Full India to Singapore Plasma Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 16,941 shipments on this route.
Frequently Asked Questions — India to Singapore Plasma Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Plasma to Singapore?
The leading Indian exporters of Plasma to Singapore are S S SERUMS, ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED, JOHNSON & JOHNSON PRIVATE LIMITED. S S SERUMS holds the largest market share at approximately 39% of total trade value on this route.
Q What is the total value of Plasma exports from India to Singapore?
India exports Plasma to Singapore worth approximately $231.6K USD across 16,941 recorded shipments. The average value per shipment is $14 USD.
Q Which ports does India use to ship Plasma to Singapore?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 5000 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 26% by air.
Q How long does shipping take from India to Singapore for Plasma?
The average transit time for Plasma shipments from India to Singapore is approximately 32 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Singapore Plasma trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 16.9% with demand growth tracking at 16.4%. The route is ranked #5 among India's top Plasma export destinations globally.
Q How many suppliers are active on the India to Singapore Plasma route?
There are currently 75 active Indian suppliers exporting Plasma to Singapore. The market is moderately concentrated with S S SERUMS accounting for 39% of total shipment value.
Q Who are the main importers of Plasma from India in Singapore?
The leading importers of Indian Plasma in Singapore include MP BIOMEDICALS ASIA PACIFIC PTE LTD, MP BIOMEDICALS ASIA PACIFIC PTE LIMITED, LABCORP DEVELOPMENT (ASIA) PTE.LTD., LABCORP DEVELOPMENT ASIA PTE LIMITE, ICON CENTRAL LABORATORIES. MP BIOMEDICALS ASIA PACIFIC PTE LTD is the largest buyer with 39 shipments worth $54.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Singapore export trade corridor identified from Indian Customs (DGFT) records for Plasma.
- 2.Supplier/Buyer Matching: 75 Indian exporters and 178 importers in Singapore matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 16,941 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
16,941 Verified Shipments
75 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists